Skip to content

Visi-Pro™ PXB35-09-17-135Recalls & reported problems

Covidien LP · PXB35-09-17-135 STENT VISI PRO 035 V01 · Class 2 · Implant

All models of Visi-Pro (66)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00643169787926), received between Apr 5, 2023 and Apr 5, 2023 — classified as 1 malfunction.

The most frequently reported specific device problem is “Use of Device Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Use of Device Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionApr 5, 2023Use of Device Problem; Use of Device Problem

    PHYSICIAN USED A VISIPRO BALLOON EXPANDABLE STENT TO TREAT A LESION IN THE PATIENTS MID COMMON ILIAC ARTERY. EMBOLIC PROTECTION WAS NOT USED. THERE WAS NO DAMAGE NOTED TO PACKAGING (I.E. SHELF CARTON, HOOP/TRAY). THERE WERE NO ISSUES NOTED WHEN REMOVING THE DEVICE FROM THE HOOP/TRAY. STENT WAS EXPIRED BUT WAS DEPLOYED ANYWAY PER IFU WITHOUT ISSUE. IT WAS REPORTED THAT THE DEVICE WAS USED 3 DAYS POST EXPIRY. NO PATIENT INJURY REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16681118 ↗

Other Stents, drains and dilators for the biliary ducts devices

All Stents, drains and dilators for the biliary ducts devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page